Indian shares extend record rally; Sensex logs longest winning run in 16 years
![](https://portfolio.investmentguruindia.com/uploads/news/33c225b467f071eb37ccb5da31fff423.jpg)
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Indian shares settled at record highs on Friday, helped by the Bajaj Auto-led surge in auto stocks, while the benchmark Sensex logged its longest daily winning streak in 16 years.
On the day, the Nifty 50 was up 0.44% to 20,192.35, while the S&P BSE Sensex gained 0.47% to 67,838.63.
Both the benchmarks gained nearly 2% each for the week and closed at record highs.
The Sensex rose for the eleventh straight session, adding 4.64% over the period, logging its longest series of daily gains since October 3, 2007.
Auto stocks climbed 1.58% to a record high, powered by a 5.9% jump in Bajaj Auto after BofA Global Research upgraded the stock to "buy" from "neutral".
Ashok Leyland gained 1.72% after signing an agreement with the Uttar Pradesh state government to set up a plant to manufacture electric buses.
The high-weightage IT index rose 0.94%, helped by rising expectations of a rate hike pause from the U.S. Federal Reserve next week.
IT firms earn a significant share of their revenue from the U.S. HCL Tech was among the top Nifty 50 gainers, rising 1.64%.
The more domestically-focussed small-caps and mid-caps settled up 0.41% and 0.28%, respectively.
They, however, snapped a three-week winning streak, dragged by the sharpest single-day fall in 2023 on Tuesday.
"There is clearly room for correction in India's mid-caps, due to rise in oil prices and renewed inflationary concerns," said Christopher Wood, global head of equity strategy at Jefferies, adding that the expected pull-back in Indian equities is a "buying opportunity".
Among individual stocks, Strides Pharma surged 5.51% and hit a 20-month high after the drugmaker's Singapore unit received tentative U.S. FDA approval for an anti-retroviral therapy drug for HIV patients.
HDFC Bank gained 1.15% ahead of the FTSE's semi-annual index review. The changes will be effective on Sept. 18.
![](https://portfolio.investmentguruindia.com/uploads/news/insurance 123.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Axis Securities Ltd.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Wipro.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/2b1715f7e03b51b0ac9c014eb224fc1f.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/gdp22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Geojit Financial Services.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Dollar retures 2.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/health22.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/Arvind Kapil, MD and CEO, Poonawalla Fincorp.jpg)
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)
Top News
![](https://portfolio.investmentguruindia.com/investmentguruimages/upload/post/2021/07/8e1771d6cc65556f1cea74bda8dca00b.jpg)
Wide-ranging reforms make India attractive destination for foreign investments: FM Nirmala S...
Tag News
![](https://portfolio.investmentguruindia.com/uploads/news/stock8.jpg)
Sensex ends lower ahead of Union Budget 2024-25
![Daily Market Analysis : The markets began the week on a subdued note and ended nearly unchanged, reflecting caution ahead of the Union Budget Says Mr. Ajit Mishra, Religare Broking Ltd](https://portfolio.investmentguruindia.com/uploads/news/Ajit Mishra.jpg)
![Post Market Comment by Mandar Bhojane, Research Analyst, Choice Broking](https://portfolio.investmentguruindia.com/uploads/news/Broker _26.jpg)
![Mid-Market Comment by Mr Shrey Jain, Founder and CEO SAS Online - India's Deep Discount Broker](https://portfolio.investmentguruindia.com/uploads/news/Shrey Jain.jpg)